Reports for GE HEALTHCARE CANADA INC

Company Name
GE HEALTHCARE CANADA INC

Shortage reports

Actual shortage:

0 (0%)

Anticipated shortage:

1 (1%)

Avoided shortage:

8 (7%)

Resolved:

98 (92%)

107

Discontinuation Reports

To be discontinued:

1 (17%)

Discontinued:

5 (83%)

Reversed:

0 (0%)

6

0 (0%)

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
VISIPAQUE 320 652MG SOLUTION Resolved 2021-08-18 2021-08-21 144296
VISIPAQUE 320 652MG SOLUTION Resolved 2022-05-13 2023-01-05 160516
VISIPAQUE 320 652MG SOLUTION Resolved 2022-05-13 2023-01-31 160519
VISIPAQUE 320 652MG SOLUTION Resolved 2024-01-26 2024-02-15 217414
VISIPAQUE 320 652MG SOLUTION Resolved 2024-01-26 2024-02-24 217420
VISIPAQUE 320 652MG SOLUTION Resolved 2024-03-07 2024-03-14 221590
VISIPAQUE 320 652MG SOLUTION Resolved 2021-07-30 2021-08-21 143297

Showing 101 to 107 of 107

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
Metastron 37 MBq/mL Solution Discontinued 2018-10-12 2019-02-01 63929
OMNIPAQUE 180 388MG SOLUTION Discontinued 2023-01-31 2023-02-22 182757
OMNIPAQUE 240 518MG SOLUTION Discontinued 2023-01-31 2023-03-18 182760
OMNISCAN 287MG SOLUTION Discontinued 2023-01-31 2023-03-25 182742
SEHCAT 370KBq CAPSULE To be discontinued 2026-02-12 2026-02-12 277848
THALLOUS CHLORIDE TI 201 INJECTION 37MBq SOLUTION Discontinued 2020-12-04 2021-06-05 129592

Showing 1 to 6 of 6